Ellen Berit N.
- Country
- Norway
- Department
- Revmatologi
Research Overview
- Evaluation of Intra-Articular Triamcinolone Hexacetonide Injections in Juvenile Idiopathic Arthritis Patients Initiating Tumor Necrosis Factor Inhibitor Therapy
- Evaluation of Methotrexate and Tumor Necrosis Factor Inhibitor Withdrawal Strategies in Juvenile Idiopathic Arthritis Remission: A Randomized Multicenter Trial
Data & Insights
Has run more than one trial at 5 of 7 partner sites.
Specializations
Pediatric Rheumatology
This investigator specializes in the treatment of Juvenile Idiopathic Arthritis (JIA), with particular emphasis on innovative therapeutic approaches for managing pediatric inflammatory joint conditions.
- JIA Treatment Optimization
- Inflammatory Disease Management
- Pediatric Joint Health
The investigator focuses on evaluating treatment strategies involving TNF inhibitors and their combination with other therapeutic interventions.
Therapeutic Interventions
Areas of clinical interest include the study of intra-articular glucocorticoid injections and their role in achieving disease remission in pediatric patients.
- Combined Therapy Approaches
- Disease Activity Management
- Treatment Optimization Strategies
The investigator examines various treatment withdrawal strategies and their impact on maintaining sustained inactive disease in young patients.
Clinical Outcomes
The investigator's work centers on achieving and maintaining inactive disease states in pediatric rheumatic conditions.
- Disease Remission Assessment
- Long-term Outcome Evaluation
- Flare Prevention Strategies
Research interests include monitoring therapeutic responses and developing strategies for sustained disease control in pediatric arthritis.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.